Bayer CropScience surged 10.41% to Rs 6219.60 after the company's net profit jumped 86% to Rs 251.70 crore on 29.2% rise in revenue from operations to Rs 1227.80 crore in Q1 FY21 over Q1 FY20.
Profit before tax in Q1 June 2020 stood at Rs 312.60 crore, up by 75.9% from Rs 177.70 crore in Q1 June 2019. Current tax expense increased 35.9% on a year-on-year (YoY) basis to Rs 55.6 crore in the June quarter.
Commenting on the Q1 results, D. Narain, CEO & managing director of Bayer CropScience, said, "Preparations for Kharif season started earlier this year due to COVID-19 related uncertainties. Consequently, we advanced our production schedule to enable early product availability and shifted to digital training & advisory for our farmer customers. On-time arrival of monsoon and uninterrupted availability of agri-inputs helped farmers procure seeds and crop protection products for timely Kharif sowing. This led to a strong demand in Q1, compared to previous years. New routes such as e-commerce sale of our brands helped us leverage our existing value chain partnerships and deliver greater value to farmers."
Sharing an outlook for the future, D. Narain, said, "COVID-19 has significantly disrupted Indian agriculture and forced players across the agri value chain to remodel their day-to-day operations and supply chains. It has also highlighted the importance of agriculture for food security, advancing rural livelihoods and the Indian economy. The government's transformational agri-reforms will provide farmers wider access to sell their produce beyond their local marketplaces and achieve better price realization. Bayer will continue to support Indian farmers through access to seeds & crop protection inputs, product innovation and crop advisory. Our focus will be on new business models and value chain collaborations to expand the reach of our agri-solutions, support scale-up of FPOs (Farmer Producer Organizations) and digital farming solutions."
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
